Thrivent Financial for Lutherans’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.17M | Sell |
16,150
-1,788
| -10% | -$347K | 0.01% | 1140 |
|
|
2025
Q4 | $3.11M | Buy |
17,938
+7,851
| +78% | +$1.43M | 0.01% | 1169 |
|
|
2025
Q3 | $1.92M | Sell |
10,087
-14,080
| -58% | -$2.5M | ﹤0.01% | 1378 |
|
|
2025
Q2 | $4.34M | Buy |
24,167
+11,351
| +89% | +$1.97M | 0.01% | 885 |
|
|
2025
Q1 | $2.17M | Sell |
12,816
-4,805
| -27% | -$789K | ﹤0.01% | 1236 |
|
|
2024
Q4 | $2.66M | Sell |
17,621
-1,346
| -7% | -$209K | 0.01% | 1249 |
|
|
2024
Q3 | $2.94M | Buy |
18,967
+9,396
| +98% | +$1.4M | 0.01% | 1198 |
|
|
2024
Q2 | $1.31M | Buy |
9,571
+244
| +3% | +$33.4K | ﹤0.01% | 1677 |
|
|
2024
Q1 | $1.24M | Sell |
9,327
-9,807
| -51% | -$1.27M | ﹤0.01% | 1762 |
|
|
2023
Q4 | $2.64M | Sell |
19,134
-1,176
| -6% | -$155K | 0.01% | 1189 |
|
|
2023
Q3 | $2.48M | Buy |
20,310
+226
| +1% | +$30.1K | 0.01% | 1153 |
|
|
2023
Q2 | $2.82M | Buy |
20,084
+8,546
| +74% | +$1.18M | 0.01% | 1120 |
|
|
2023
Q1 | $1.63M | Buy |
11,538
+1,856
| +19% | +$266K | ﹤0.01% | 1438 |
|
|
2022
Q4 | $1.51M | Sell |
9,682
-798
| -8% | -$115K | ﹤0.01% | 1452 |
|
|
2022
Q3 | $1.29M | Sell |
10,480
-220
| -2% | -$29K | ﹤0.01% | 1508 |
|
|
2022
Q2 | $1.42M | Buy |
10,700
+2,122
| +25% | +$289K | ﹤0.01% | 1463 |
|
|
2022
Q1 | $1.17M | Buy |
8,578
+1,303
| +18% | +$182K | ﹤0.01% | 1725 |
|
|
2021
Q4 | $1.18M | Sell |
7,275
-1,091
| -13% | -$166K | ﹤0.01% | 1750 |
|
|
2021
Q3 | $1.22M | Buy |
8,366
+746
| +10% | +$109K | ﹤0.01% | 1702 |
|
|
2021
Q2 | $1M | Sell |
7,620
-2,811
| -27% | -$368K | ﹤0.01% | 1835 |
|
|
2021
Q1 | $1.34M | Sell |
10,431
-23,000
| -69% | -$2.83M | ﹤0.01% | 1687 |
|
|
2020
Q4 | $3.98M | Sell |
33,431
-14,910
| -31% | -$1.82M | 0.01% | 947 |
|
|
2020
Q3 | $5.53M | Buy |
48,341
+8,119
| +20% | +$959K | 0.01% | 765 |
|
|
2020
Q2 | $4.58M | Buy |
40,222
+11,906
| +42% | +$1.26M | 0.01% | 741 |
|
|
2020
Q1 | $2.27M | Buy |
28,316
+22,177
| +361% | +$2.3M | 0.01% | 898 |
|
|
2019
Q4 | $656K | Buy |
6,139
+90
| +1% | +$9.39K | ﹤0.01% | 1743 |
|
|
2019
Q3 | $647K | Hold |
6,049
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q2 | $616K | Buy |
6,049
+55
| +0.9% | +$5.29K | ﹤0.01% | 1695 |
|
|
2019
Q1 | $539K | Buy |
5,994
+58
| +1% | +$5.03K | ﹤0.01% | 1766 |
|
|
2018
Q4 | $494K | Buy |
5,936
+104
| +2% | +$9.75K | ﹤0.01% | 1576 |
|
|
2018
Q3 | $629K | Buy |
5,832
+129
| +2% | +$14.1K | ﹤0.01% | 1566 |
|
|
2018
Q2 | $627K | Sell |
5,703
-26,515
| -82% | -$2.76M | ﹤0.01% | 1549 |
|
|
2018
Q1 | $3.23M | Buy |
32,218
+26,683
| +482% | +$2.73M | 0.01% | 752 |
|
|
2017
Q4 | $545K | Buy |
5,535
+105
| +2% | +$9.95K | ﹤0.01% | 1635 |
|
|
2017
Q3 | $508K | Buy |
5,430
+230
| +4% | +$24.4K | ﹤0.01% | 1562 |
|
|
2017
Q2 | $578K | Buy |
5,200
+100
| +2% | +$10.6K | ﹤0.01% | 1433 |
|
|
2017
Q1 | $501K | Buy |
5,100
+220
| +5% | +$21K | ﹤0.01% | 1535 |
|
|
2016
Q4 | $449K | Buy |
4,880
+300
| +7% | +$25.9K | ﹤0.01% | 1553 |
|
|
2016
Q3 | $387K | Buy |
4,580
+160
| +4% | +$13.4K | ﹤0.01% | 1591 |
|
|
2016
Q2 | $360K | Buy |
4,420
+190
| +4% | +$14.5K | ﹤0.01% | 1575 |
|
|
2016
Q1 | $303K | Sell |
4,230
-31,060
| -88% | -$2.08M | ﹤0.01% | 1607 |
|
|
2015
Q4 | $2.51M | Sell |
35,290
-40,380
| -53% | -$2.71M | 0.01% | 782 |
|
|
2015
Q3 | $4.65M | Sell |
75,670
-102,510
| -58% | -$7.17M | 0.02% | 575 |
|
|
2015
Q2 | $12.9M | Sell |
178,180
-44,320
| -20% | -$3.27M | 0.07% | 273 |
|
|
2015
Q1 | $17.1M | Buy |
222,500
+218,900
| +6,081% | +$15.7M | 0.09% | 237 |
|
|
2014
Q4 | $242K | Hold |
3,600
| – | – | ﹤0.01% | 1506 |
|
|
2014
Q3 | $218K | Sell |
3,600
-51,300
| -93% | -$3.16M | ﹤0.01% | 1546 |
|
|
2014
Q2 | $3.22M | Buy |
+54,900
| New | +$3.22M | 0.02% | 603 |
|
|
2013
Q4 | – | Sell |
-3,600
| Closed | -$222K | – | 1578 |
|
|
2013
Q3 | $222K | Sell |
3,600
-1,900
| -35% | -$114K | ﹤0.01% | 1394 |
|
|
2013
Q2 | $333 | Buy |
+5,500
| New | +$328K | ﹤0.01% | 1128 |
|
Other funds holding DGX
VCM
VPM
EIG
Thrivent Financial for Lutherans's DGX Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Quest Diagnostics (DGX) stake by 10% in Q1 2026, selling an estimated $347K and leaving 16,150 shares worth $3.17M. The position accounts for 0.01% of the portfolio, ranked #1140.
Thrivent Financial for Lutherans first reported a position in DGX in Q2 2013 and has held it in 50 quarters since. The position peaked at $17.1M in Q1 2015. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Thrivent Financial for Lutherans held 16,150 shares of Quest Diagnostics worth $3.17M as of Q1 2026.
- Thrivent Financial for Lutherans sold 1,788 Quest Diagnostics shares in Q1 2026, an estimated $347K.
- Quest Diagnostics made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1140 holding.
- Thrivent Financial for Lutherans first reported a position in Quest Diagnostics in Q2 2013 and has held it in 50 quarters since.
- Thrivent Financial for Lutherans's Quest Diagnostics position peaked at $17.1M in Q1 2015.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.